Nicotine as an Approved Substance: Exploring Its Role in Smoking Cessation and Harm Reduction

Nicotine, widely known for its association with tobacco products, is also recognized as an approved drug by health authorities such as the World Health Organization (WHO). In therapeutic contexts, nicotine plays a pivotal role in smoking cessation strategies, offering safer alternatives to combustible tobacco use. When delivered without the harmful effects of combustion, nicotine replacement…

Embracing Change and Challenges: Insights from the Global Institute for Novel Nicotine

At the inaugural session of GINN’s in-person panels, hosted by the Global Institute for Novel Nicotine (GINN), key industry leaders gathered to address the evolving landscape of the nicotine pouch industry. This landmark event was not only a platform for sharing insights but also for delineating the path forward amid changing regulatory environments and market…

Global Anti-Smoking Index 2024: Insights from Around the World

The 2024 Global Anti-Smoking Index, as presented by “We Are Innovation” highlights significant advancements in tobacco control and harm reduction strategies across diverse regions. While certain nations shine as leaders in this space, others lag behind, underscoring the urgent need for equitable and effective global tobacco policies. European Nations Dominate the Top 20 European countries…

Exploring the Insights of Professor Fredrik Nystrom: A New Perspective on Health and Metabolism

Recently, I came across an update on Sweden’s progress that included fascinating insights from Professor Fredrik Nystrom.His perspectives were nothing short of captivating, particularly his insights on the metabolic interplay between nicotine and coffee. Inspired by his talk, I have begun reading his book, which challenges many conventional health norms with a refreshing scientific rigor.…

Reflecting on the Leading with Innovation: Sweden’s Path to Smoke-Free Event in London

Congratulations to Suely Castro and Federico N. Fernández, CEO of We Are Innovation for organizing such an impactful event! It was an incredible experience to attend Leading with Innovation: Sweden’s Path to Smoke-Free, where we celebrated Sweden’s remarkable journey toward a smoke-free future. 🌍🎉 A special shoutout to the keynote and panel speakers: Sweden has…

The Case Against Nicotine Pouch Bans: Overlooked Potential for Smoking

Recent global trends indicate a growing inclination among governments to impose bans or stringent regulations on nicotine pouches. While these measures are often driven by public health concerns, they may inadvertently overlook the potential of nicotine pouches as effective tools for smoking cessation and harm reduction. France’s Prohibition on Nicotine Pouches In October 2024, France…

Vape Bans Could Undermine Smoking Reduction Efforts, Warns GINN

Dated: 27 August 2024 The Global Institute for Novel Nicotine (GINN) has issued a strong warning against proposed government restrictions on vape products, emphasizing that such measures could hinder progress in helping smokers transition to less harmful alternatives. As a newly formed organization advocating for harm reduction, GINN is committed to advancing innovation and evidence-based…